Audio long read: Conquering Alzheimer’s — a l...

Nature staff discuss an AI tool that can assess the impact of nine billion mutations — plus, how the Bunsen burner’s reputation for sterilization may be based on tradition alone.00:21 Deepmind’s new tool helps scientists find the impact of mutationsNature: DeepMind’s new genome ‘ ...  عرض المزيد

In this episode:00:46 How telephone teaching could boost education during school shutdownsNature: Pick up the phone! Phone calls with tutors keep kids learning when schools shut down11:42 Research HighlightsNature: Super-precise optical clocks in four nations tick in harmonyNatur ...  عرض المزيد

This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  عرض المزيد

An experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ...  عرض المزيد